These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 29571260)
1. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma. Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway. Zheng L; Chen J; Zhou Z; He Z Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142. Yang G; Song R; Wang L; Wu X Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904 [TBL] [Abstract][Full Text] [Related]
4. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression. Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728 [No Abstract] [Full Text] [Related]
5. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204. Zhou H; Ma Y; Zhong D; Yang L Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2. Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA RHPN1-AS1 exerts pro-oncogenic actions in osteosarcoma by functioning as a molecular sponge of miR-506 to positively regulate SNAI2 expression. Wang L; Liu Y Cell Cycle; 2020 Jun; 19(12):1517-1529. PubMed ID: 32401134 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo. Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755 [TBL] [Abstract][Full Text] [Related]
9. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma. Ye H; Lin J; Yao X; Li Y; Lin X; Lu H Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771 [TBL] [Abstract][Full Text] [Related]
11. Luo Y; Tao H; Jin L; Xiang W; Guo W Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892 [No Abstract] [Full Text] [Related]
12. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway. Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway. Zhong X; Cai Y Bioengineered; 2021 Dec; 12(2):9113-9127. PubMed ID: 34802389 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458. Gui D; Cao H In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):24-33. PubMed ID: 31950433 [TBL] [Abstract][Full Text] [Related]
15. HOXD-AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer. Xu K; Feng Y J Cell Biochem; 2019 Apr; 120(4):5326-5332. PubMed ID: 30317670 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a. Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1. Lu X; Qiao L; Liu Y J Cell Biochem; 2020 Oct; 121(10):4064-4073. PubMed ID: 31930565 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1. Wang Z; Wang Z; Liu J; Yang H Biomed Pharmacother; 2018 Nov; 107():598-605. PubMed ID: 30114643 [TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis. Yan F; Ma Y; Liu L; Li L; Deng J; Sun J J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404 [TBL] [Abstract][Full Text] [Related]
20. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN. Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]